BRONTUSS SF-NR- dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride liquid

Brontuss by

Drug Labeling and Warnings

Brontuss by is a Otc medication manufactured, distributed, or labeled by Portal Pharmaceutical, Great Southern Laboratories. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Drug Facts

Active ingredients
(in each 5 mL teaspoonful)
Dextromethorphan Hydrobromide 15 mg
Guaifenesin 300 mg
Phenylephrine Hydrochloride 10 mg

Purpose

Antitussive
Expectorant
Nasal Decongestant

Uses

Temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies:

• cough due to minor throat and bronchial irritation
• helps phlegm (mucus) and thin bronchial secretions to drain bronchial tubes and make coughs more productive
• nasal congestion
• reduces swelling of nasal passages
  

Warnings

Do not exceed recommended dosage.

Do not use this product

• if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug.  If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
  

Ask a doctor before use if you have

• a cough that lasts or is chronic such as occurs with smoking, asthma, chronic bronchitis or emphysema
• a cough that occurs with too much phlegm (mucus)
• heart disease
• high blood pressure
• thyroid disease
• diabetes
• trouble urinating due to an enlarged prostate gland
  

Stop use and ask a doctor if

• nervousness, dizziness, or sleeplessness occur
• cough or nasal congestion persists for more than 1 week, tends to recur, or is accompanied by a fever, rash, or persistent headache.  A persistent cough may be a sign of a serious condition.
  

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

Do not exceed recommended dosage.

• Adults and Children 12years of ageand over: 1 teaspoonful (5 mL); every 4 hours, not to; exceed 6 doses in 24; hours.
• Children 6 tounder 12years of age: 1/2 teaspoonful (2.5 mL); every 4 hours, not to; exceed 6 doses in 24; hours.
• Children under 6 yearsof age: Consult a doctor.

Other information

• Each 5 mL teaspoonful contains 5 mg sodium.
• Store at 59°-86° F (15°-30° C)
  

Inactive ingredients

citric acid, glycerin, grape flavor, propylene glycol, purified water, sodium citrate, sodium saccharin, sorbitol.

Questions? Comments?

Call your doctor for medical advice about side effects.  Serious side effects associated with this product may be reported to this number.
Call (787) 832-6645.  Operation Hours: Monday - Friday, 8 A.M. to 4 P.M. Atlantic Standard Time (AST)
portalpharmaceutical@gmail.com

Manufactured for:
Portal Pharmaceutical
Mayaguez, PR  00681

Rev. 11/11

Product Packaging

The packaging below represents the labeling currently used.

Principal display panel and side panel for 30 mL label:

NDC: 49963-381-01

Brontuss
SF-NR
Liquid

· Antitussive · Expectorant
· Nasal Decongestant

Each teaspoonful (5 mL) for
oral administration contains:
Dextromethorphan HBr....................15 mg
Guaifenesin..................................300 mg
Phenylephrine HCl..........................10 mg

Grape Flavor
Dye Free · Sugar Free · Alcohol Free

1 oz. (30 mL)

Tamper evident by foil seal under cap.  Do not use if
foil seal is broken or missing.
Supplied in a tight, light-resistant container with a child-
resistant cap.

Manufactured for:
PORTAL
Pharmaceutical
Mayaguez, PR  00680                         Rev. 11/11

Professional Sample:  Not For Sale

INGREDIENTS AND APPEARANCE

BRONTUSS  SF-NR
dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride liquid

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 49963-381
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
Dextromethorphan Hydrobromide (UNII: 9D2RTI9KYH) (Dextromethorphan - UNII:7355X3ROTS)	Dextromethorphan Hydrobromide	15 mg  in 5 mL
Guaifenesin (UNII: 495W7451VQ) (Guaifenesin - UNII:495W7451VQ)	Guaifenesin	300 mg  in 5 mL
Phenylephrine Hydrochloride (UNII: 04JA59TNSJ) (Phenylephrine - UNII:1WS297W6MV)	Phenylephrine Hydrochloride	10 mg  in 5 mL

Inactive Ingredients
Ingredient Name	Strength
Citric Acid Monohydrate (UNII: 2968PHW8QP)
Glycerin (UNII: PDC6A3C0OX)
Water (UNII: 059QF0KO0R)
Sodium Citrate (UNII: 1Q73Q2JULR)
Saccharin Sodium (UNII: SB8ZUX40TY)
Sorbitol (UNII: 506T60A25R)

Product Characteristics
Color		Score
Shape		Size
Flavor	GRAPE	Imprint Code
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 49963-381-01	30 mL in 1 BOTTLE
2	NDC: 49963-381-04	118 mL in 1 BOTTLE

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph final	part341	12/22/2011

Labeler - Portal Pharmaceutical (831005199)

Registrant - Great Southern Laboratories (056139553)

Establishment
Name	Address	ID/FEI	Business Operations
Great Southern Laboratories		056139553	manufacture